Protein Name |
Pfam ID |
Percentage of Identity (%) |
E value |
Mixed lineage kinase 1 (MAP3K9)
|
|
29.097 (87/299) |
2.19E-25 |
MST-1 protein kinase (STK4)
|
|
26.736 (77/288) |
7.25E-22 |
NIMA-related kinase 7 (NEK7)
|
|
25.714 (72/280) |
1.09E-21 |
Omphalocele kinase 1 (NUAK1)
|
|
28.723 (81/282) |
6.22E-21 |
Ribosomal protein S6 kinase alpha-2 (RSK2)
|
|
28.938 (79/273) |
7.95E-21 |
Serine/threonine-protein kinase 3 (STK3)
|
|
26.389 (76/288) |
9.19E-21 |
Serine/threonine-protein kinase 24 (STK24)
|
|
27.007 (74/274) |
1.83E-20 |
Ribosomal protein S6 kinase alpha-3 (RSK3)
|
|
28.832 (79/274) |
8.58E-20 |
NIMA-related kinase 6 (NEK6)
|
|
23.469 (69/294) |
1.60E-19 |
Ribosomal protein S6 kinase alpha-1 (RSK1)
|
|
28.205 (77/273) |
4.14E-19 |
Ribosomal protein S6 kinase alpha-6 (RSK6)
|
|
27.536 (76/276) |
5.26E-19 |
Microtubule affinity regulating kinase 3 (MARK3)
|
|
30.208 (87/288) |
6.26E-19 |
Oxidative stress responsive 1 (OXSR1)
|
|
23.885 (75/314) |
1.34E-18 |
Serine/threonine-protein kinase 10 (STK10)
|
|
28.216 (68/241) |
1.53E-18 |
Serine/threonine-protein kinase 33 (STK33)
|
|
27.626 (71/257) |
4.40E-18 |
Salt-inducible kinase 2 (SIK2)
|
|
29.964 (83/277) |
5.10E-18 |
Ste-20-related kinase (STK39)
|
|
25.796 (81/314) |
5.20E-18 |
Unc-51 like kinase 3 (ULK3)
|
|
25.806 (80/310) |
6.64E-18 |
NUAK family SNF1-like kinase 2 (NUAK2)
|
|
27.402 (77/281) |
6.75E-18 |
Serine/threonine-protein kinase Nek5 (NEK5)
|
|
23.741 (66/278) |
8.31E-18 |
Serine/threonine-protein kinase MARK1 (MARK1)
|
|
31.224 (74/237) |
8.50E-18 |
Putative serine/threonine-protein kinase SIK1B (SIK1B)
|
|
27.338 (76/278) |
2.64E-17 |
Salt-inducible kinase 1 (SIK1)
|
|
27.338 (76/278) |
2.78E-17 |
MAP/microtubule affinity-regulating kinase 4 (MARK4)
|
|
30.342 (71/234) |
3.07E-17 |
Serine/threonine-protein kinase MARK2 (MARK2)
|
|
29.514 (85/288) |
4.88E-17 |
Testis-specific serine kinase 2 (TSSK2)
|
|
26.596 (75/282) |
5.50E-17 |
STE20-related serine/threonine-protein kinase (SLK)
|
|
28.049 (69/246) |
5.83E-17 |
Serine/threonine-protein kinase 26 (STK26)
|
|
26.596 (75/282) |
5.83E-17 |
Serine/threonine-protein kinase 25 (STK25)
|
|
25.547 (70/274) |
7.26E-17 |
Leucine-rich repeat kinase 2 (LRRK2)
|
|
28.947 (88/304) |
8.60E-17 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
|
|
27.848 (88/316) |
1.21E-16 |
Testis-specific serine/threonine-protein kinase 6 (TSSK6)
|
|
26.761 (76/284) |
1.94E-16 |
Fused homolog (STK36)
|
|
26.754 (61/228) |
2.24E-16 |
Putative 3-phosphoinositide-dependent protein kinase 2 (PDPK2P)
|
|
26.860 (65/242) |
3.18E-16 |
ERK activator kinase 2 (MEK2)
|
|
28.448 (66/232) |
4.05E-16 |
Aurora kinase A (AURKA)
|
|
23.209 (81/349) |
4.87E-16 |
Protein kinase C theta (PRKCQ)
|
|
25.071 (88/351) |
4.90E-16 |
Phosphoinositide dependent protein kinase-1 (PDPK1)
|
|
27.935 (69/247) |
7.69E-16 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 (PRKAA2)
|
|
28.014 (79/282) |
8.51E-16 |
Myosin-IIIb (MYO3B)
|
|
27.931 (81/290) |
4.01E-15 |
ERK activator kinase 5 (MAP2K5)
|
|
24.633 (84/341) |
5.12E-15 |
Leucine-rich repeat serine/threonine-protein kinase 1 (LRRK1)
|
|
25.392 (81/319) |
5.28E-15 |
RAC-beta serine/threonine-protein kinase (AKT2)
|
|
26.296 (71/270) |
5.38E-15 |
ERK activator kinase 1 (MEK1)
|
|
26.754 (61/228) |
7.62E-15 |
PAK-2 protein kinase (PAK2)
|
|
22.601 (73/323) |
1.14E-14 |
RAC-gamma serine/threonine-protein kinase (AKT3)
|
|
26.296 (71/270) |
1.23E-14 |
Serine/threonine-protein kinase ULK1 (ULK1)
|
|
27.799 (72/259) |
1.77E-14 |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
|
25.364 (87/343) |
2.32E-14 |
Serine/threonine-protein kinase Nek8 (NEK8)
|
|
27.076 (75/277) |
2.49E-14 |
Polo-like kinase 2 (PLK2)
|
|
22.789 (67/294) |
2.64E-14 |
SPS1/STE20-related protein kinase YSK4 (YSK4)
|
|
25.714 (72/280) |
2.81E-14 |
SIK family kinase 3 (SIK3)
|
|
26.786 (75/280) |
3.93E-14 |
Calcium/calmodulin-dependent protein kinase type 1 (CAMK1)
|
|
25.939 (76/293) |
4.72E-14 |
cAMP-dependent protein kinase catalytic subunit beta (PRKACB)
|
|
24.232 (71/293) |
5.20E-14 |
MAPK/ERK kinase kinase 1 (MAP3K1)
|
|
23.077 (69/299) |
5.55E-14 |
Myosin light chain kinase family member 4 (MYLK4)
|
|
24.749 (74/299) |
5.76E-14 |
Serine/threonine-protein kinase ULK2 (ULK2)
|
|
25.292 (65/257) |
6.02E-14 |
Apoptosis signal-regulating kinase 1 (MAP3K5)
|
|
25.623 (72/281) |
7.02E-14 |
Ribosomal protein S6 kinase beta-1 (S6K1)
|
|
27.119 (64/236) |
9.37E-14 |
Serine/threonine-protein kinase Nek11 (NEK11)
|
|
22.867 (67/293) |
1.06E-13 |
Serine/threonine-protein kinase Nek4 (NEK4)
|
|
24.407 (72/295) |
1.14E-13 |
Serine/threonine-protein kinase Sgk1 (SGK1)
|
|
24.063 (77/320) |
1.54E-13 |
Testis-specific serine/threonine-protein kinase 1 (TSSK1B)
|
|
24.823 (70/282) |
1.81E-13 |
Protein kinase C delta (PRKCD)
|
|
26.389 (76/288) |
2.04E-13 |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
|
23.592 (88/373) |
2.13E-13 |
cAMP-dependent protein kinase catalytic subunit alpha (PRKACA)
|
|
24.839 (77/310) |
2.23E-13 |
Serine/threonine-protein kinase Nek3 (NEK3)
|
|
22.628 (62/274) |
2.31E-13 |
Myosin light chain kinase 2 (MYLK2)
|
|
28.226 (70/248) |
2.81E-13 |
Cyclin-dependent kinase 6 (CDK6)
|
|
26.577 (59/222) |
3.42E-13 |
Doublecortin-like kinase 3 (DCLK3)
|
|
28.070 (80/285) |
3.59E-13 |
Myosin light chain kinase 3 (MYLK3)
|
|
27.083 (65/240) |
3.62E-13 |
Cyclin-dependent kinase-like 4 (CDKL4)
|
|
25.322 (59/233) |
3.64E-13 |
Cyclin-dependent kinase 2 (CDK2)
|
|
25.311 (61/241) |
3.76E-13 |
Serine/threonine-protein kinase PAK 3 (PAK3)
|
|
22.662 (63/278) |
4.59E-13 |
Serine/threonine-protein kinase ICK (CILK1)
|
|
28.125 (63/224) |
4.86E-13 |
Myosin-IIIa (MYO3A)
|
|
25.952 (75/289) |
4.93E-13 |
Cyclin-dependent kinase 5 (CDK5)
|
|
25.200 (63/250) |
6.42E-13 |
Inhibitor of nuclear factor kappa-B kinase beta (IKKB)
|
|
25.316 (60/237) |
6.70E-13 |
BR serine/threonine kinase 1 (BRSK1)
|
|
27.018 (77/285) |
7.18E-13 |
PKC-delta-interacting protein kinase (RIPK4)
|
|
25.685 (75/292) |
8.94E-13 |
Serine/threonine-protein kinase NIM1 (NIM1K)
|
|
27.049 (66/244) |
9.33E-13 |
PAK-1 protein kinase (PAK1)
|
|
22.302 (62/278) |
9.69E-13 |
Serine/threonine-protein kinase PAK 5 (PAK5)
|
|
25.455 (70/275) |
1.04E-12 |
Aurora kinase C (AURKC)
|
|
23.636 (65/275) |
1.18E-12 |
cAMP-dependent protein kinase catalytic subunit gamma (PRKACG)
|
|
24.188 (67/277) |
1.25E-12 |
Cyclin-dependent kinase 3 (CDK3)
|
|
25.221 (57/226) |
1.28E-12 |
Calcium/calmodulin-dependent protein kinase type 1G (CAMK1G)
|
|
26.761 (76/284) |
1.39E-12 |
MEK kinase kinase 1 (MAP4K1)
|
|
23.675 (67/283) |
1.50E-12 |
Serine/threonine-protein kinase Nek9 (NEK9)
|
|
22.491 (65/289) |
1.64E-12 |
Serine/threonine-protein kinase PLK3 (PLK3)
|
|
21.222 (66/311) |
2.03E-12 |
Ribosomal protein S6 kinase beta-2 (RPS6KB2)
|
|
24.014 (67/279) |
2.12E-12 |
Polo-like kinase 4 (PLK4)
|
|
23.741 (66/278) |
2.66E-12 |
Serine/threonine-protein kinase Nek10 (NEK10)
|
|
24.038 (75/312) |
3.11E-12 |
NIMA-related kinase 2 (NEK2)
|
|
23.000 (69/300) |
3.14E-12 |
Death-associated protein kinase 1 (DAPK1)
|
|
24.476 (70/286) |
3.24E-12 |
Maternal embryonic leucine zipper kinase (MELK)
|
|
25.368 (69/272) |
3.47E-12 |
Cyclin-dependent kinase 7 (CDK7)
|
|
25.287 (66/261) |
3.57E-12 |
Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)
|
|
25.532 (72/282) |
3.88E-12 |
Serine/threonine-protein kinase PAK 6 (PAK6)
|
|
25.877 (59/228) |
4.09E-12 |
Serine/threonine-protein kinase STK11 (STK11)
|
|
22.635 (67/296) |
4.29E-12 |
Cyclin-dependent kinase 17 (CDK17)
|
|
25.758 (68/264) |
4.53E-12 |
Protein kinase N1 (PKN1)
|
|
27.206 (74/272) |
4.56E-12 |
Testis-specific serine/threonine-protein kinase 4 (TSSK4)
|
|
26.316 (80/304) |
5.93E-12 |
Protein kinase N2 (PKN2)
|
|
25.524 (73/286) |
6.64E-12 |
Serine/threonine-protein kinase MAK (MAK)
|
|
25.676 (57/222) |
6.88E-12 |
Polo-like kinase 1 (PLK1)
|
|
22.857 (64/280) |
8.96E-12 |
Cyclin-dependent kinase-like 1 (CDKL1)
|
|
26.180 (61/233) |
9.25E-12 |
Cyclin-dependent kinase-like 3 (CDKL3)
|
|
26.496 (62/234) |
9.69E-12 |
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3)
|
|
26.959 (86/319) |
1.12E-11 |
Cyclin-dependent kinase 16 (CDK16)
|
|
25.475 (67/263) |
1.52E-11 |
BR serine/threonine kinase 2 (BRSK2)
|
|
27.049 (66/244) |
1.97E-11 |
Calmodulin-dependent kinase II (CAMKK2)
|
|
24.793 (60/242) |
1.98E-11 |
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
|
24.092 (73/303) |
1.98E-11 |
SNF-related serine/threonine-protein kinase (SNRK)
|
|
25.806 (72/279) |
2.22E-11 |
Cyclin-dependent kinase 1 (CDK1)
|
|
27.273 (63/231) |
2.36E-11 |
Calcium/calmodulin-dependent protein kinase type 1D (CAMK1D)
|
|
25.623 (72/281) |
2.78E-11 |
Cyclin-dependent kinase 18 (CDK18)
|
|
26.957 (62/230) |
2.97E-11 |
IL-1 receptor-associated kinase 1 (IRAK1)
|
|
27.039 (63/233) |
3.60E-11 |
Protein kinase C alpha (PRKCA)
|
|
24.354 (66/271) |
4.56E-11 |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
|
23.843 (67/281) |
5.95E-11 |
PAK-4 protein kinase (PAK4)
|
|
22.667 (68/300) |
6.20E-11 |
NIMA-related kinase 1 (NEK1)
|
|
24.138 (70/290) |
6.55E-11 |
MAPK/MAK/MRK overlapping kinase (MOK)
|
|
25.833 (62/240) |
6.91E-11 |
PDZ binding kinase (PBK)
|
|
23.308 (62/266) |
7.34E-11 |
TRAF2 and NCK interacting kinase (TNIK)
|
|
25.368 (69/272) |
7.91E-11 |
Apoptosis signal-regulating kinase 2 (MAP3K6)
|
|
26.374 (72/273) |
8.14E-11 |
Protein kinase C epsilon (PRKCE)
|
|
26.160 (62/237) |
1.00E-10 |
MAPK/ERK kinase kinase 3 (MAP3K3)
|
|
27.155 (63/232) |
1.17E-10 |
Cyclin-dependent kinase-like 5 (CDKL5)
|
|
23.404 (55/235) |
1.20E-10 |
Death-associated protein kinase 3 (DAPK3)
|
|
23.427 (67/286) |
1.54E-10 |
Protein kinase G2 (PRKG2)
|
|
23.571 (66/280) |
1.63E-10 |
Nik-related protein kinase (NRK)
|
|
24.214 (77/318) |
1.65E-10 |
Calcium/calmodulin-dependent protein kinase type 1B (PNCK)
|
|
25.641 (70/273) |
1.72E-10 |
Cyclin-dependent kinase 14 (CDK14)
|
|
25.000 (61/244) |
1.86E-10 |
Doublecortin-like kinase 1 (DCLK1)
|
|
23.571 (66/280) |
2.24E-10 |
Checkpoint kinase-1 (CHK1)
|
|
27.397 (60/219) |
2.26E-10 |
Death-associated protein kinase 2 (DAPK2)
|
|
25.210 (60/238) |
2.36E-10 |
Inhibitor of nuclear factor kappa-B kinase alpha (IKKA)
|
|
27.234 (64/235) |
2.62E-10 |
Serine/threonine-protein kinase 32C (STK32C)
|
|
22.263 (61/274) |
2.95E-10 |
MAPK/ERK kinase kinase 2 (MAP3K2)
|
|
27.468 (64/233) |
3.25E-10 |
Serine/threonine-protein kinase Sgk3 (SGK3)
|
|
25.322 (59/233) |
3.32E-10 |
Serine/threonine-protein kinase 32A (STK32A)
|
|
21.118 (68/322) |
3.42E-10 |
Tyrosine-protein kinase EIF2AK2 (p68)
|
|
21.242 (65/306) |
4.01E-10 |
TAO kinase 3 (TAOK3)
|
|
24.910 (69/277) |
4.64E-10 |
Doublecortin-like kinase 2 (DCLK2)
|
|
24.126 (69/286) |
4.99E-10 |
Serine/threonine-protein kinase H1 (PSKH1)
|
|
26.860 (65/242) |
5.14E-10 |
Aurora kinase B (AURKB)
|
|
25.424 (60/236) |
5.88E-10 |
Misshapen-like kinase 1 (MINK1)
|
|
25.000 (63/252) |
6.32E-10 |
Cyclin-dependent kinase 15 (CDK15)
|
|
24.549 (68/277) |
7.23E-10 |
Serine/threonine-protein kinase TAO2 (TAOK2)
|
|
26.457 (59/223) |
7.86E-10 |
Serine/threonine-protein kinase Sgk2 (SGK2)
|
|
22.222 (72/324) |
8.69E-10 |
Putative serine/threonine-protein kinase PRKY (PRKY)
|
|
23.276 (54/232) |
8.69E-10 |
Protein kinase C eta type (PRKCH)
|
|
24.055 (70/291) |
8.81E-10 |
Protein kinase C beta (PRKCB)
|
|
23.985 (65/271) |
9.02E-10 |
G protein-coupled receptor kinase 6 (GRK6)
|
|
26.549 (60/226) |
9.24E-10 |
Cyclin-dependent kinase 13 (CDK13)
|
|
25.764 (59/229) |
9.27E-10 |
TAO kinase 1 (TAOK1)
|
|
27.092 (68/251) |
1.05E-09 |
Myosin light kinase (MYLK)
|
|
22.559 (67/297) |
1.08E-09 |
Serine/threonine-protein kinase 17B (STK17B)
|
|
24.625 (82/333) |
1.25E-09 |
Yet another novel kinase 2 (STK32B)
|
|
20.120 (67/333) |
1.43E-09 |
Protein kinase G1 (PRKG1)
|
|
22.509 (61/271) |
1.47E-09 |
MAP kinase p38 (MAPK12)
|
|
26.316 (60/228) |
1.76E-09 |
Cyclin-dependent kinase 12 (CDK12)
|
|
26.522 (61/230) |
1.79E-09 |
Testis-specific serine/threonine-protein kinase 3 (TSSK3)
|
|
26.126 (58/222) |
1.84E-09 |
Calcium/calmodulin-dependent protein kinase type IV (CAMK4)
|
|
28.125 (63/224) |
1.93E-09 |
Serine/threonine-protein kinase SBK1 (SBK1)
|
|
26.293 (61/232) |
2.01E-09 |
cAMP-dependent protein kinase catalytic subunit PRKX (PRKX)
|
|
24.569 (57/232) |
2.40E-09 |
Cyclin-dependent kinase-like 2 (CDKL2)
|
|
23.301 (72/309) |
2.77E-09 |
Proto-oncogene serine/threonine-protein kinase mos (MOS)
|
|
22.581 (70/310) |
2.93E-09 |
G protein-coupled receptor kinase 5 (GRK5)
|
|
26.316 (60/228) |
3.27E-09 |
Stress-activated protein kinase 2b (p38 beta)
|
|
25.311 (61/241) |
3.46E-09 |
Extracellular signal-regulated kinase 5 (ERK5)
|
|
25.328 (58/229) |
3.74E-09 |
Serine/threonine-protein kinase PDIK1L (PDIK1L)
|
|
25.468 (68/267) |
3.93E-09 |
Serine/threonine-protein kinase H2 (PSKH2)
|
|
21.992 (53/241) |
4.34E-09 |
MEK kinase kinase 3 (MAP4K3)
|
|
22.456 (64/285) |
5.40E-09 |
Cytoplasmic DRAK1 (STK17A)
|
|
24.638 (68/276) |
6.32E-09 |
Stress-activated protein kinase 2a (p38 alpha)
|
|
29.480 (51/173) |
6.42E-09 |
TGF-beta receptor type I (TGFBR1)
|
|
23.171 (76/328) |
7.68E-09 |
Ribosomal protein S6 kinase alpha-4 (RPS6KA4)
|
|
22.360 (72/322) |
7.72E-09 |
Cyclin-dependent kinase 20 (CDK20)
|
|
25.214 (59/234) |
8.52E-09 |
MEK kinase kinase 2 (MAP4K2)
|
|
22.449 (66/294) |
9.48E-09 |
Cyclin-dependent kinase 4 (CDK4)
|
|
27.232 (61/224) |
9.68E-09 |
Serine/threonine-protein kinase cot (COT)
|
|
23.810 (70/294) |
1.14E-08 |
Cyclin-dependent kinase 9 (CDK9)
|
|
23.684 (54/228) |
1.22E-08 |
Hormonally up-regulated neu tumor-associated kinase (HUNK)
|
|
22.566 (51/226) |
1.31E-08 |
Protein kinase N3 (PKN3)
|
|
25.941 (62/239) |
1.45E-08 |
Protein kinase C iota (PRKCI)
|
|
24.034 (56/233) |
1.61E-08 |
Obscurin (OBSCN)
|
|
24.312 (53/218) |
1.69E-08 |
ERK activator kinase 7 (MAP2K7)
|
|
22.500 (72/320) |
1.84E-08 |
Serine/threonine-protein kinase pim-2 (PIM2)
|
|
26.712 (78/292) |
2.66E-08 |
Mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5)
|
|
22.807 (65/285) |
2.97E-08 |
Rhodopsin kinase GRK1 (GRK1)
|
|
23.404 (66/282) |
2.99E-08 |
MEK kinase kinase 4 (MAP4K4)
|
|
24.901 (63/253) |
3.53E-08 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A)
|
|
24.296 (69/284) |
4.50E-08 |
G protein-coupled receptor kinase 4 (GRK4)
|
|
25.221 (57/226) |
5.65E-08 |
Activin receptor type IB (ACVR1B)
|
|
23.770 (58/244) |
5.69E-08 |
Ribosomal protein S6 kinase alpha-5 (RSK5)
|
|
25.000 (60/240) |
5.75E-08 |
Serine/threonine-protein kinase Chk2 (RAD53)
|
|
24.390 (80/328) |
5.96E-08 |
Serine/threonine-protein kinase tousled-like 2 (TLK2)
|
|
25.105 (60/239) |
6.72E-08 |
Serine/threonine-protein kinase tousled-like 1 (TLK1)
|
|
25.907 (50/193) |
8.43E-08 |
TBC domain-containing protein kinase-like protein (TBCK)
|
|
23.350 (46/197) |
9.39E-08 |
Extracellular signal-regulated kinase 1 (ERK1)
|
|
29.524 (31/105) |
1.03E-07 |
Microtubule-associated serine/threonine-protein kinase 3 (MAST3)
|
|
22.121 (73/330) |
1.12E-07 |
Mitogen-activated protein kinase 4 (MAPK4)
|
|
26.500 (53/200) |
1.24E-07 |
MAPK/ERK kinase kinase 4 (MAP3K4)
|
|
21.147 (59/279) |
1.34E-07 |
Serine/threonine-protein kinase NLK (NLK)
|
|
34.409 (32/93) |
1.43E-07 |
Mitogen-activated protein kinase 13 (MAPK13)
|
|
25.000 (58/232) |
1.59E-07 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
|
23.466 (65/277) |
1.79E-07 |
Serine/threonine-protein kinase 35 (STK35)
|
|
24.762 (78/315) |
1.96E-07 |
CaM-kinase IV kinase (CAMKK1)
|
|
29.412 (45/153) |
2.18E-07 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE)
|
|
24.390 (60/246) |
2.24E-07 |
Dual specificity protein kinase TTK (MPS1)
|
|
20.848 (59/283) |
2.84E-07 |
Serine/threonine-protein kinase D2 (PRKD2)
|
|
27.632 (63/228) |
3.04E-07 |
Striated muscle preferentially expressed protein kinase (SPEG)
|
|
24.464 (57/233) |
3.60E-07 |
Protein kinase C gamma (PRKCG)
|
|
26.761 (38/142) |
3.89E-07 |
Protein kinase D (PRKD1)
|
|
25.794 (65/252) |
3.90E-07 |
Ribosomal protein S6 kinase-related protein (RSKR)
|
|
35.106 (33/94) |
3.96E-07 |
Calcium/calmodulin-dependent protein kinase type II subunit beta (CAMK2B)
|
|
22.826 (63/276) |
4.44E-07 |
Extracellular signal-regulated kinase 2 (ERK2)
|
|
28.571 (30/105) |
4.49E-07 |
Phosphorylase kinase testis gamma 2 (PHKG2)
|
|
25.541 (59/231) |
4.58E-07 |
Mitogen-activated protein kinase 15 (MAPK15)
|
|
25.000 (61/244) |
6.49E-07 |
Eukaryotic translation initiation factor 2-alpha kinase 1 (EIF2AK1)
|
|
30.159 (38/126) |
6.57E-07 |
Serine/threonine-protein kinase WNK1 (WNK1)
|
|
24.229 (55/227) |
8.30E-07 |
NF-kappa-B-activating kinase (TBK1)
|
|
25.620 (62/242) |
9.53E-07 |
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
|
|
27.419 (51/186) |
1.63E-06 |
Peripheral plasma membrane protein CASK (CASK)
|
|
24.303 (61/251) |
1.65E-06 |
Serine/threonine-protein kinase D3 (PRKD3)
|
|
28.000 (63/225) |
1.67E-06 |
Protein kinase C zeta (PRKCZ)
|
|
21.769 (64/294) |
1.76E-06 |
Serine/threonine-protein kinase WNK4 (WNK4)
|
|
23.276 (54/232) |
2.00E-06 |
Bone morphogenetic protein receptor (BMPR2)
|
|
24.340 (83/341) |
2.10E-06 |
Rhodopsin kinase GRK7 (GRK7)
|
|
23.009 (52/226) |
2.45E-06 |
Wee1-like protein kinase (WEE1)
|
|
23.000 (69/300) |
2.52E-06 |
Dual-specificity tyrosine-phosphorylation regulated kinase 3 (DYRK3)
|
|
36.538 (38/104) |
3.33E-06 |
Serine/threonine-protein kinase pim-1 (PIM1)
|
|
27.273 (42/154) |
3.78E-06 |
PRKR-like endoplasmic reticulum kinase (PERK)
|
|
30.303 (30/99) |
3.99E-06 |
Microtubule-associated serine/threonine-protein kinase 4 (MAST4)
|
|
30.702 (35/114) |
4.23E-06 |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
|
23.265 (57/245) |
4.59E-06 |
Microtubule-associated serine/threonine-protein kinase 2 (MAST2)
|
|
21.912 (55/251) |
5.02E-06 |
Microtubule-associated serine/threonine-protein kinase 1 (MAST1)
|
|
29.565 (34/115) |
5.24E-06 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHKG1)
|
|
25.248 (51/202) |
5.78E-06 |
Mitogen-activated protein kinase 6 (MAPK6)
|
|
22.467 (51/227) |
6.50E-06 |
Titin (TTN)
|
23.043 (53/230) |
6.98E-06 |
Wee1-like protein kinase 2 (WEE2)
|
|
26.667 (48/180) |
7.07E-06 |
WNK lysine-deficient protein kinase 3 (WNK3)
|
|
22.768 (51/224) |
7.60E-06 |
Homeodomain-interacting protein kinase 4 (HIPK4)
|
|
25.424 (60/236) |
8.81E-06 |
Cyclin-dependent kinase 8 (CDK8)
|
|
26.512 (57/215) |
9.16E-06 |
Cyclin-dependent kinase 11A (CDK11A)
|
|
22.523 (50/222) |
1.05E-05 |
Cyclin-dependent kinase 19 (CDK19)
|
|
27.778 (65/234) |
1.34E-05 |
Serine/threonine-protein kinase WNK2 (WNK2)
|
|
24.194 (45/186) |
1.53E-05 |
MAPK-activated protein kinase 2 (MAPKAPK2)
|
|
27.072 (49/181) |
1.63E-05 |
Activin receptor type IIA (ACVR2A)
|
|
23.661 (53/224) |
2.10E-05 |
Serine/threonine-protein kinase greatwall (MASTL)
|
|
23.034 (41/178) |
2.65E-05 |
Stress-activated protein kinase JNK3 (JNK3)
|
|
31.183 (29/93) |
3.51E-05 |
PAS domain-containing serine/threonine-protein kinase (PASK)
|
|
24.896 (60/241) |
3.66E-05 |
Casein kinase II alpha (CSNK2A1)
|
|
26.923 (28/104) |
4.46E-05 |
Cyclin-dependent kinase 11B (CDK11B)
|
|
22.523 (50/222) |
4.96E-05 |
Stress-activated protein kinase JNK1 (JNK1)
|
|
31.183 (29/93) |
5.29E-05 |
IL-1 receptor-associated kinase 3 (IRAK3)
|
|
21.702 (51/235) |
5.50E-05 |
Cyclin-G-associated kinase (GAK)
|
|
20.721 (69/333) |
5.62E-05 |
Citron Rho-interacting kinase (CIT)
|
|
24.275 (67/276) |
5.65E-05 |
Rho-associated protein kinase 2 (ROCK2)
|
|
23.810 (55/231) |
5.67E-05 |
Stress-activated protein kinase JNK2 (JNK2)
|
|
31.183 (29/93) |
6.10E-05 |
Anti-mullerian hormone II receptor (AMHR2)
|
|
23.692 (77/325) |
6.25E-05 |
Glycogen synthase kinase-3 alpha (GSK-3A)
|
|
22.041 (54/245) |
6.35E-05 |
Triple functional domain protein (TRIO)
|
|
24.123 (55/228) |
9.92E-05 |
Rho-associated protein kinase 1 (ROCK1)
|
|
24.242 (56/231) |
1.11E-04 |
Cyclin-dependent kinase 10 (CDK10)
|
|
24.658 (54/219) |
1.14E-04 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1A (DYRK1A)
|
|
26.087 (60/230) |
1.15E-04 |
CDC-like kinase 1 (CLK1)
|
|
24.800 (62/250) |
1.19E-04 |
Casein kinase II subunit alpha 3 (CSNK2A3)
|
|
25.962 (27/104) |
1.55E-04 |
Dual-specificity tyrosine-phosphorylation regulated kinase 1B (DYRK1B)
|
|
25.652 (59/230) |
1.58E-04 |
STE20-related kinase adapter protein alpha (STRADA)
|
|
21.759 (47/216) |
1.61E-04 |
Dual-specificity tyrosine-phosphorylation regulated kinase 2 (DYRK2)
|
|
33.645 (36/107) |
1.63E-04 |
CaM kinase-like vesicle-associated protein (CAMKV)
|
|
24.309 (44/181) |
1.80E-04 |
CDC-like kinase 2 (CLK2)
|
|
22.500 (54/240) |
1.83E-04 |
Serine/threonine kinase-like domain-containing protein STKLD1 (STKLD1)
|
|
24.684 (39/158) |
1.83E-04 |
Glycogen synthase kinase-3 beta (GSK-3B)
|
|
21.702 (51/235) |
1.86E-04 |
Homeodomain-interacting protein kinase 3 (HIPK3)
|
|
23.729 (56/236) |
2.28E-04 |
Serine/threonine-protein kinase 40 (STK40)
|
|
22.353 (38/170) |
4.79E-04 |
Homeodomain-interacting protein kinase 1 (HIPK1)
|
|
22.619 (76/336) |
5.36E-04 |
Serine/threonine-protein kinase SBK2 (SBK2)
|
|
25.110 (57/227) |
6.94E-04 |
Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4)
|
|
25.974 (40/154) |
7.83E-04 |
Adaptor-associated kinase 1 (AAK1)
|
|
23.350 (46/197) |
8.92E-04 |
Homeodomain interacting protein kinase 2 (HIPK2)
|
|
23.305 (55/236) |
1.00E-03 |
Tribbles homolog 2 (TRIB2)
|
|
24.324 (36/148) |
1.00E-03 |
Dual-specificity tyrosine-phosphorylation regulated kinase 4 (DYRK4)
|
|
29.808 (31/104) |
2.00E-03 |
CDC-like kinase 4 (CLK4)
|
|
24.481 (59/241) |
2.00E-03 |
Serine/threonine-protein kinase PRP4 homolog (PRPF4B)
|
|
25.820 (63/244) |
3.00E-03 |
Activin receptor type IIB (ACVR2B)
|
|
21.951 (54/246) |
3.00E-03 |
Serine/threonine-protein kinase NIK (MAP3K14)
|
|
23.077 (54/234) |
3.00E-03 |
Serine/threonine-protein kinase LATS1 (LATS1)
|
|
21.965 (38/173) |
4.00E-03 |
Beta-adrenergic receptor kinase 1 (ADRBK1)
|
|
23.841 (36/151) |
4.00E-03 |
Serine/threonine-protein kinase Kist (UHMK1)
|
|
27.273 (33/121) |
4.00E-03 |
Click to Show/Hide the Information of Human Similarity Proteins |